News Releases

February 9, 2018

Researchers collected and compared data of ventilated patients with and w/out ventilator-associated pneumonia (VAP) after heart surgery to determine the additional cost to treat patients who developed VAP.

February 6, 2018

How does the US compare against the rest of the world regarding GDP spending on health care?

February 5, 2018

A lot has happened in the ten years since the inception of ENCePP. Here’s what this European Medicines Agency supported network has achieved so far:

January 17, 2018

In the US, there are large disparities between racial and ethnic populations in HIV incidence, and levels of care. This research looks at how improving HIV care in all racial and ethnic groups would impact HIV incidence and measures of disparity.

January 15, 2018

Chronic migraines can be debilitating and may be associated with medication overuse, which makes it important that any treatment for the condition must be effective and well tolerated by patients. In Phase III clinical trials, onabotulinumtoxinA was shown to be safe for use as a preventative for...

January 10, 2018

Through presentation and hands-on exercises, participants will learn to design and build a budget impact model and interpret the results.

December 20, 2017

Carcinoid syndrome is caused by cancerous carcinoid tumors that secrete chemicals–including serotonin–into the bloodstream. These secretions can cause a variety of symptoms including frequent watery bowel movements (BMs). Telotristat ethyl, a serotonin inhibitor, was studied in the Phase III...

December 5, 2017

Angelman syndrome (AS) is a rare genetic disorder that causes a range of impairments.  Affected individuals have severe to profound intellectual disabilities, seizures, behavioral issues, and challenges with communicating, walking, and sleeping.

November 20, 2017

New research also indicates that cost may override both factors for patients with most prevalent type of leukemia

November 8, 2017

Our goal for this study, was to demonstrate the advantages of using longitudinal data methods

October 4, 2017

Patients receiving chemotherapy frequently experience febrile neutropenia (FN), a dose-limiting toxicity that may disrupt planned chemotherapy administration (such as causing delays or dose reduction). This toxicity may necessitate hospitalization, which can be prolonged, costly, and may...

October 2, 2017

The UNC Gillings School of Global Public Health is doing something new. This fall for the first time, they are teaching a special topics course in pharmacovigilance as part of their pharmacoepidemiology curriculum.  

Essential Education

September 19, 2017

Allen Mangel, MD, PhD, and Executive Vice President of RTI-HS, examines evidence that supports a different understanding of the behavior of the aorta during the cardiac cycle. Article published in J of Cardio Pharma.

August 25, 2017

Patient preference has the potential to inform a host of issues from initial device or drug development to post-marketing surveillance.  While patient preference studies in health care research are becoming common, their use in regulatory decision making is relatively new. 

August 17, 2017

Several members of the RTI-HS team recently attended the National Institute for Health and Care Excellence (NICE) 2017 conference in Liverpool, UK—a valuable way for our team to stay abreast of updates and ensure we have the appropriate understanding to guide our clients through the ever-...

August 10, 2017

The risks associated with respiratory syncytial virus (RSV) in newborns are generally well known. Parents of infants – particularly babies who were born prematurely – are routinely educated on precautions to protect their newborns against exposure, and pediatricians are vigilant about...

August 10, 2017

Recent law updates medical device regulation in the US. In the EU - greater transparency in post-market follow-up.

August 7, 2017

This comprehensive guide to the methods for preparing budget-impact analyses that adhere to published guidelines is a must have for the builder and budget holder.
The first of its kind for budget-impact analysis,

July 20, 2017

As part of a post-approval safety commitment to the U.S.

July 6, 2017

Research conducted to test the real-world feasibility and value of the BEDS-7 screening tool has recently been published in The Primary Care Companion for CNS Disorders.

June 26, 2017

RTI Health Solutions is pleased to announce that Ken Rothman, DrPH, Distinguished Fellow and Vice President for Epidemiology Research, has been awarded the Career Accomplishment Award by the Society for Epidemiologic Research (SER). Rothman received a plaque to commemorate the award on June 22nd...

June 23, 2017

RTI Health Solutions is honored to have staff that are leaders in research and academia. Our researchers often serve on industry advisory boards and teach at universities and industry sponsored courses.   Dr. Susana Perez-Gutthann, Vice President and Global Head of Epidemiology, recently...

June 19, 2017

Research currently relies mostly on pregnancy exposure registries to gather data for safety studies once drugs are on the market. RTI Health Solutions researchers believe that, for many of those studies, there is a better way to collect that data.

June 15, 2017

Nepafenac is a non-steroidal anti-inflammatory drug approved to treat pain and inflammation in the first 2 weeks following cataract surgery in adults. In 2016, a new indication for this drug was approved – prevention of postoperative macular edema in patients with diabetes for use up to 60 days...

June 7, 2017

RTI Health Solutions’ James Kaye has just returned from a very busy American Society of Clinical Oncology (ASCO) Annual Meeting. He shares these insights from that meeting.

Pages